about
New treatment options against gram-negative organismsCarbapenems: past, present, and futureCrystal Structures of Biapenem and Tebipenem Complexed with Penicillin-Binding Proteins 2X and 1A from Streptococcus pneumoniaeEfficacy and safety of biapenem in treatment of infectious disease: a meta-analysis of randomized controlled trialsEpileptogenic potential of carbapenem agents: mechanism of action, seizure rates, and clinical considerations.Drug discovery from natural sources.Comparison of the pharmacodynamics of biapenem in bronchial epithelial lining fluid in healthy volunteers given half-hour and three-hour intravenous infusionsBiapenem versus meropenem in the treatment of bacterial infections: a multicenter, randomized, controlled clinical trial.New antibiotics for bad bugs: where are we?Development of novel antibacterial drugs to combat multiple resistant organisms.In vitro and in vivo activity of biapenem against drug-susceptible and rifampicin-resistant Mycobacterium tuberculosis.Efficacy and safety of biapenem against lower respiratory tract infections in elderly Chinese patients and optimal dosing regimen based on pharmacokinetic/pharmacodynamic analysis.In vitro activity of Biapenem plus RPX7009, a carbapenem combined with a serine β-lactamase inhibitor, against anaerobic bacteria.Pharmacokinetics and disposition of CS-023 (RO4908463), a novel parenteral carbapenem, in animals.Clinical and microbiological effects of biapenem in febrile neutropenic patients with hematologic malignancies.Population pharmacokinetics and pharmacodynamics of biapenem in paediatric patients.An enzoinformatics study for prediction of efficacies of three novel penem antibiotics against New Delhi metallo-β-lactamase-1 bacterial enzyme.
P2860
Q21194906-086719A0-8AB4-40BE-BEF9-F0976E45E754Q24634999-03429BEE-D318-4771-92C3-B09561DF2B73Q27650232-D3DCB2D6-AECD-4C83-BF14-8FEFB10E6FCBQ28251775-75F30FD6-6007-42DE-9CE4-A89BDE77E237Q34026343-5592D9FF-1F7A-4003-A4E8-85F298474915Q35594873-E0E9ADF6-DF1F-46FF-9FCE-20B21A3C3E19Q37247635-B9001D6C-7D9C-43D8-ACEE-AFC497FFDC31Q37690875-366007F0-7401-40CC-B1C6-B61443898F4CQ38132217-3683C826-0D23-4F5D-939E-A6E1A4A0A1BCQ38350301-56125C9E-2540-4D82-A6E5-0C55B73CD523Q40187337-00E8B0CC-6E0D-4061-9D68-B4B6B784A5D8Q40968893-DCDEFEF6-4956-46B8-BFB2-AED90131CC92Q42110245-BB063CF9-C04E-40CB-9342-05DBC62074E0Q42112315-85CFE7D7-DBD6-417B-B0BC-7E225FE1E7CCQ46178973-907D92BA-3599-4C9A-BE82-3B3B8C86E1CBQ46721813-EC0F79F4-1B9B-4011-8B79-3ED233040E13Q53027926-B261AC78-D0CC-4C86-B9F1-3BCCDF388120
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Biapenem.
@ast
Biapenem.
@en
Biapenem.
@nl
type
label
Biapenem.
@ast
Biapenem.
@en
Biapenem.
@nl
prefLabel
Biapenem.
@ast
Biapenem.
@en
Biapenem.
@nl
P1433
P1476
Biapenem.
@en
P2093
Tim Ibbotson
P304
2221-34; discussion 2235
P356
10.2165/00003495-200262150-00005
P577
2002-01-01T00:00:00Z
P6179
1025237398